Role of nitric oxide (NO) in interferon-alpha therapy for hepatitis C-Reference-Cited by-同舟云学术

Role of nitric oxide (NO) in interferon-alpha therapy for hepatitis C

Published:2005-07 Issue:1 Volume:51 Page:47-53
ISSN:0163-4453
Container-title:Journal of Infection
language:en
Short-container-title:Journal of Infection

Author:

Hokari Atsushi,Zeniya Mikio,Esumi Hiroyasu,Ishikawa Tomohisa,Kurasima Yukiko,Toda Gotaro

Publisher

Elsevier BV

Subject

Infectious Diseases,Microbiology (medical)

Reference44 articles.

1. Treatment of chronic non-A, non-B hepatitis with recombinant human alpha interferon. A preliminary report;Hoofnagle;N Engl J Med,1986

2. Randomized trial comparing three different regimens of alpha-2a-interferon in chronic hepatitis C. The TriVeneto Viral Hepatitis Group;Chemello;Hepatology,1995

3. High sustained response rate and clearance of viremia in chronic hepatitis C after treatment with interferon-alpha 2b for 60 weeks;Reichard;Hepatology,1994

4. Interferon alfa-2b for chronic hepatitis C: effects of dose increment and duration of treatment on response rates. Results of the first multicentre Australian trial. Australia Hepatitis C Study Group;Lin;J Hepatol,1995

5. Detection of hepatitis C virus by polymerase chain reaction and response to interferon-alpha therapy: relationship to genotypes of hepatitis C virus;Yoshioka;Hepatology,1992

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Type I Interferon Supports Inducible Nitric Oxide Synthase in Murine Hepatoma Cells and Hepatocytes and during Experimental Acetaminophen-Induced Liver Damage;Frontiers in Immunology;2017-07-31

2. Profile of oxidative stress markers is dependent on vitamin D levels in patients with chronic hepatitis C;Nutrition;2016-03

3. Asymmetric dimethylarginine as a mediator of vascular dysfunction in cirrhosis;World Journal of Gastroenterology;2015

4. Role of Oxidative Stress in Hepatitis B and C Virus;Role of Oxidative Stress in Chronic Diseases;2014-02-20

5. Hepatitis C Virus, Oxidative Stress and Steatosis: Current Status and Perspectives;Current Molecular Medicine;2011-07-01